Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis
Authors:
- 10 May 2022
- journal article
- letter
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 59, 182-183
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centrePostgraduate Medical Journal, 2021
- Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: A systematic review and meta-analysisThe American Journal of Emergency Medicine, 2021
- Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019—The pilot studyJournal of Medical Virology, 2021
- Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concernsClinical Microbiology and Infection, 2021
- Remdesivir for the Treatment of Covid-19 — Final ReportNew England Journal of Medicine, 2020